Evidence map›Paper›PMID 16340246›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2006

Silencing the hsp25 gene eliminates migration capability of the highly metastatic murine 4T1 breast adenocarcinoma cell.

Maria A Bausero, Ajit Bharti, Diana T Page, Kristen D Perez, Jason W-L Eng, Susana L Ordonez, Edwina E Asea, Christian Jantschitsch, Ingela Kindas-Muegge, Daniel Ciocca and 1 more

Open access · greenAbstract read
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Peptide aptamers: tools to negatively or positively modulate HSPB1(27) function.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2013
    Review
  10. Article
  11. Article
  12. Review
  13. Overexpression of SASH1 related to the decreased invasion ability of human glioma U251 cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2012
    Article
  14. Effects of SASH1 on lung cancer cell proliferation, apoptosis, and invasion in vitro.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2012
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Maria A BauseroCenter for Molecular Stress Response, Boston University Medical Center and Boston University School of Medicine, Mass., USA.
Ajit Bharti
Diana T Page
Kristen D Perez
Jason W-L Eng
Susana L Ordonez
Edwina E Asea
Christian Jantschitsch
Ingela Kindas-Muegge
Daniel Ciocca
Alexzander Asea
Boston Medical Center · USBoston University · USInstituto de Medicina y Biología Experimental de Cuyo · ARLudwig Boltzmann Institute for Cancer Research · ATUniversity Medical Center · USUniversity of Vienna · AT

Funding

Circulating HSP70 in Hyperthermia and Cancer TherapyR01CA091889 · NCI · SCOTT AND WHITE MEMORIAL HOSPITAL · PI ASEA, ALEXZANDER A · 2003 to 2006
$1.3M
NCI NIH HHS R01 CA091889NCI NIH HHS R01 CA091889-05
6 · The paper itself

Abstract

The 25-kDa heat shock protein (Hsp25) is associated with various malignancies and is expressed at high levels in biopsies as well as circulating in the serum of breast cancer patients. In this study, we used RNA interference technology to silence the hsp25 gene in 4T1 breast adenocarcinoma cells, known as a poorly immunogenic, highly metastatic cell line. We demonstrate that transfection of 4T1 cells with short interference RNA-Hsp25 dramatically inhibits proliferation as compared with control transfected cells. In addition, we show that 4T1 cells transfected with short interference RNA-Hsp25 abrogates tumor migration potential by a mechanism that is in part due to the repression of matrix metalloproteinase 9 expression and a concomitant upregulation of its antagonist, tissue inhibitor metalloproteinase 1. Taken together, these findings provide a model system for the study of metastatic potential of tumors and are suggestive of an earlier unrecognized role for Hsp25 in tumor migration.

Indexed as

RNA InterferenceAdenocarcinomaBase SequenceBreast NeoplasmsCell MovementCell ProliferationFemaleHeat-Shock ProteinsHSP27 Heat-Shock ProteinsHumansMatrix Metalloproteinase 9Molecular ChaperonesMolecular Sequence DataNeoplasm MetastasisNeoplasm ProteinsTransfectionHeat-Shock ProteinsHSP27 Heat-Shock ProteinsHSPB1 protein, humanMatrix Metalloproteinase 9Molecular ChaperonesNeoplasm Proteins

Identifiers

PMID16340246
PMCPMC1764206
OpenAlexW1970946311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.